Improvement in staging of prostate cancer

Three-dimensional transrectal ultrasonography (3D-TRUS) allows accurate 3D examination of pathological structures and prediction of extracapsular tumor extension.

Medisons Accuvix XQ Prestige 07 - a real-time 3D US scanner.
Medison's Accuvix XQ Prestige 07 - a real-time 3D US scanner.
180 randomly selected patiens with initial diagnosed prostate cancer participated in a study at the Medical University of Innsbruck. Dr. Michael Mitterberger and colleagues used 3D-TRUS, which provides ultrasonograms in three planes simultaneously, for local staging of prostate cancer.

“3D-TRUS can be used with no problems and is a simple procedure allowing exact assessement for staging prostate cancer,” said Dr, Mitterberger. “Locally confined and locally advanced prostate cancer can be differentiated with maximum convenience, reliability, and ease.”
3D-TRUS highly increase chances to detect pathological capsular perforation of the tumor: It predicted 44 of 53 cases correctly and features an overall accuracy of 96%.

The investigators conclude their report in the July issue of BJU International: “3D-Trus can be considered to guide the decision before a planned radical prostatectomy. If 3D-TRUS indicated locally advanced disease, the probability of capsular perforation or seminal vesicle invasion is very high.”

05.08.2007

More on the subject:

Related articles

Photo

News • Targeted drug activation

Ultrasound-triggered chemotherapy to reduce side-effects

Researchers explore how ultrasound waves can be used to activate chemotherapy drugs only in targeted areas, offering a new path toward safer, more effective cancer treatment.

Photo

News • Multi-lens ultrasound arrays

4D blood flow imaging of whole organs

3D + time: a new 4D ultrasound imaging technique could both improve our understanding of the circulatory system and facilitate the diagnosis of certain blood circulation-related diseases.

Photo

News • Orthopedic ultrasound screening

AI helps spot signs of dysplasia in infant hips

Developmental dysplasia of the hip occurs in 2-4% of infants, but screening via ultrasound is notoriously hard to master. An AI-assisted application could prevent many unnecessary hospital referrals.

Related products

Subscribe to Newsletter